“I Wish to Continue Receiving the Reminder Short Messaging Service”: A Mixed Methods Study on the Acceptability of Digital Adherence Tools Among Adults Living with HIV on Antiretroviral Treatment in Tanzania

Autor: Ngowi K, Pima F, Mmbaga BT, Aarnoutse RE, Reiss P, Nieuwkerk PT, Sprangers M, Sumari-de Boer M

Publikováno v: Patient Preference and Adherence, Vol Volume 15, Pp 559-568 (2021)

Kennedy Ngowi,1,2 Francis Pima,1 Blandina Theophil Mmbaga,1,3,4 Rob E Aarnoutse,5 Peter Reiss,6,7 Pythia T Nieuwkerk,2 Mirjam Sprangers,2 Marion Sumari-de Boer1 1Kilimanjaro Clinical Research Institute, Moshi, Tanzania; 2Amsterdam UMC, Location AMC,

Externí odkaz: https://doaj.org/article/704cec82901149f687627ad682d934e6

The Role of Efflux Pumps in Tuberculosis Treatment and Their Promise as a Target in Drug Development: Unraveling the Black Box

Autor: te Brake, LHM, Knegt, Gerjo, de Steenwinkel, Jurriaan, van Dam, TJP, Burger, DM, Russel, FGM, van Crevel, R, Koenderink, JB, Aarnoutse, RE

Publikováno v: Annual Review of Pharmacology and Toxicology, Vol 58, 58, 271-291

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::06daffc3e0b417eb6f9fe1cb9b42367f
https://pure.eur.nl/en/publications/bbdbbdac-f569-4cb1-9829-f8af606491f9

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

Autor: Nahid, Payam, Phillips, PPJ, Dooley, KE, Gillespie, SH, Heinrich, N, Stout, JE, Diacon, AH, Aarnoutse, RE, Kibiki, GS, Boeree, MJ

Publikováno v: Nahid, Payam; Phillips, PPJ; Dooley, KE; Gillespie, SH; Heinrich, N; Stout, JE; et al.(2016). A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP). UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/8cv271t5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::0aa2b68d6582a0665731a17cc7854072
http://www.escholarship.org/uc/item/8cv271t5

Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations

Autor: Burger, DM, Hugen, PWH, Aarnoutse, RE, Hoetelmans, RMW, Jambroes, M, Nieuwkerk, PT, Schreij, G, Schneider, MME, Ende, Marchina, Lange, JMA, Gyssens, ICJ (Inge), de Marie, S (Siem)

Publikováno v: Therapeutic Drug Monitoring, 25, 73-80
Therapeutic drug monitoring, 25(1), 73-80. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 25, 1, pp. 73-80
Therapeutic Drug Monitoring, 25, 73-80. Lippincott Williams & Wilkins

Contains fulltext : 119497.pdf (Publisher’s version ) (Closed access) The relationship between plasma concentrations of nelfinavir and virologic treatment failure was investigated to determine the minimum effective concentration of nelfinavir. Plas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1a6e2771977a6e281d3a28f2a02754
http://hdl.handle.net/2066/119497

Retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy

Autor: Burger, DM, Hugen, PWH, Aarnoutse, RE, Dieleman, Jeanne, Prins, JM, van der Poll, T, ten Veen, JH, Mulder, PGH (Paul), Meenhorst, PL, Blok, WL, van der Meer, JTM, Reiss, P, Lange, JMA

Publikováno v: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 26, 218-224. Lippincott Williams & Wilkins

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::4ddfdc11105948e8651071c6de1f5824
https://pure.eur.nl/en/publications/93013e73-2535-49b5-996b-eae7d8fd03c9